Table 1.
Data sets | Number of cases | Number of controls | Total | Genotyping platform |
---|---|---|---|---|
UK-la | 831 | 1030 | 1861 | Sequenom iPLEX Goldb |
USA-la | 1383 | 1086 | 2469 | Sequenom iPLEX Goldb |
Finland | 799 | 1082 | 1881 | Sequenom iPLEX Goldb |
Germany | 937 | 920 | 1857 | Sequenom iPLEX Goldb |
Italy | 830 | 642 | 1472 | TaqMan (7900 Sequence Detection System)c |
Sweden | 2103 | 1733 | 3836 | Sequenom iPLEX Goldb |
UK-2 | 590 | 749 | 1339 | Sequenom iPLEX Goldb |
USA-2 | 612 | 535 | 1147 | Sequenom iPLEX Goldb |
Total | 8085 | 7777 | 15862 |
These collections correspond to the ones used in the replication phase of the published genome-wide meta-analysis study.7
SEQUENOM Inc, San Diego, CA, USA.
Applied Biosystems, Foster City, CA, USA.